International experts produce guidelines for treating hereditary hearing loss with gene therapy

Up to 60% of congenital and early-onset hearing loss is caused by genetic mutations in an inherited gene, and gene therapy has recently emerged as a potential treatment option. To provide a standardized framework for conducting safe, high-quality clinical trials, a group of international experts has put together guidelines on the administration of gene therapy for hereditary hearing loss.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup